Home » Headlines » Currently Reading:

Morning Headlines 3/23/20

March 22, 2020 Headlines No Comments

CMS Announces Relief for Clinicians, Providers, Hospitals and Facilities Participating in Quality Reporting Programs in Response to COVID-19

CMS will grant exceptions for reporting requirements and data-submission extensions for healthcare providers participating in Medicare quality reporting programs.

Boris Johnson met with healthtech startups Babylon and Thriva to discuss scaling up coronavirus testing

The UK government enlists the help of healthcare and consumer technology companies to address the coronavirus pandemic.

Pence’s medical licensing comment stirs confusion

Vice President Pence’s statement about waiving state licensure limitations on telehealth doctors has created confusion, since only states can waive those restrictions, few have done so, and the federal government’s legal authority to preempt states is not clear.

Negative for ‘Coronavirus,’ positive for COVID-19: Stanford Medicine reformats reports after confusion

Stanford Health redesigns lab reports in its MyHealth portal after several students complained that their reports indicated testing negative for coronavirus, only to be notified soon afterward that they were positive for COVID-19.



HIStalk Featured Sponsors

     







Founding Sponsors


 

Platinum Sponsors


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gold Sponsors


 

 

 

 

 

 

 

 

 

 

 

 

Reader Comments

  • Sam Lawrence: Les Claypool, Primus...
  • Matthew Holt: I went back to look at when Mr H first recommended Muse. It was https://histalk2.com/2009/10/24/monday-morning-update-1...
  • Matthew Holt: Modern (ish) day bassists? think you have to include Chris Wolstenholme from Muse, who to my shame/delight I heard abo...
  • Nehal Vapi: Nice Article! The coronavirus has had unprecedented impacts on the world — and the worst is yet to come. Companies mus...
  • detroitvseverybody: The most surprising aspect of the Teladoc-Livongo deal is how investors and healthcare analysts don't seem to understand...

Sponsor Quick Links